These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 319323)

  • 21. [The effect of cephalexin on thrombocyte function in diabetics and normal persons].
    Peters KM; Reuter HD
    Arzneimittelforschung; 1987 Jul; 37(7):843-6. PubMed ID: 3675681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Blood platelet function, plasma serotonin and lipid metabolism in patients with diabetic nephropathy].
    Małyszko J; Małyszko J; Myśliwiec M
    Pol Arch Med Wewn; 1995 Jul; 94(1):26-31. PubMed ID: 8524696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased von Willebrand factor in diabetes mellitus.
    Lufkin EG; Fass DN; O'Fallon WM; Bowie EJ
    Metabolism; 1979 Jan; 28(1):63-6. PubMed ID: 310504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet coagulant activities in diabetes mellitus. Evidence for relationship between platelet coagulant hyperactivity and platelet volume.
    Rao AK; Goldberg RE; Walsh PN
    J Lab Clin Med; 1984 Jan; 103(1):82-92. PubMed ID: 6690642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma cofactors of platelet function: correlation with diabetic retinopathy and hemoglobins Ala-c.
    Coller BS; Frank RN; Milton RC; Gralnick HR
    Ann Intern Med; 1978 Mar; 88(3):311-6. PubMed ID: 305223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Platelet aggregation in diabetes mellitus at various stages of development of retinopathy].
    Titova SI; Gincherman EZ
    Probl Endokrinol (Mosk); 1979; 25(4):6-11. PubMed ID: 471973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating platelet aggregates induced by somatostatin in insulin-dependent diabetic subjects.
    Coppola L; Giugliano D; Tirelli A; Misso L; Sgambato S; D'Onofrio F
    Diabete Metab; 1980 Dec; 6(4):245-9. PubMed ID: 6110570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating platelet-leukocyte aggregates: a marker of microvascular injury in diabetic patients.
    Elalamy I; Chakroun T; Gerotziafas GT; Petropoulou A; Robert F; Karroum A; Elgrably F; Samama MM; Hatmi M
    Thromb Res; 2008; 121(6):843-8. PubMed ID: 17825880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inverse relationship between ristocetin co-factor levels and platelet aggregation in insulin dependent diabetes.
    Porta M; McCraw A; Kohner EM
    Thromb Res; 1982 Mar; 25(6):507-12. PubMed ID: 6981229
    [No Abstract]   [Full Text] [Related]  

  • 30. Increased platelet arachidonic acid metabolism in diabetes mellitus.
    Halushka PV; Mayfield R; Wohltmann HJ; Rogers RC; Goldberg AK; McCoy SA; Loadholt CB; Colwell JA
    Diabetes; 1981; 30(Suppl 2):44-8. PubMed ID: 6795072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased synthesis of prostaglandin-E-like material by platelets from patients with diabetes mellitus.
    Halushka PV; Lurie D; Colwell JA
    N Engl J Med; 1977 Dec; 297(24):1306-10. PubMed ID: 917087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet aggregation, platelet cAMP levels and thromboxane B2 synthesis in patients with diabetes mellitus.
    Chen SY; Yu BJ; Liang YQ; Lin WD
    Chin Med J (Engl); 1990 Apr; 103(4):312-8. PubMed ID: 2167823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased thromboplastic potential in diabetes: a multifactorial phenomenon.
    Landgraf-Leurs MM; Ladik T; Smolka B; Bock T; Schramm W; Spannagl M; Landgraf R
    Klin Wochenschr; 1987 Jul; 65(13):600-6. PubMed ID: 3626428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet aggregation in type I diabetics with and without proliferative retinopathy.
    Agardh CD; Agardh E; Bauer B
    Acta Ophthalmol (Copenh); 1987 Jun; 65(3):358-62. PubMed ID: 3618162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet proteins (beta-TG and PF4) in atherosclerosis and related diseases.
    Mühlhauser I; Schernthaner G; Silberbauer K; Sinzinger H; Kaliman J
    Artery; 1980; 8(1):73-9. PubMed ID: 6158934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct animal and indirect human evidence of altered platelet function in diabetics.
    Hockaday TD
    Metabolism; 1979 Apr; 28(4 Suppl 1):415-22. PubMed ID: 162473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low phospholipid arachidonic acid values in diabetic platelets.
    Jones DB; Carter RD; Haitas B; Mann JI
    Br Med J (Clin Res Ed); 1983 Jan; 286(6360):173-5. PubMed ID: 6401517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of vitamin E on platelet aggregation in diabetes mellitus.
    Watanabe J; Umeda F; Wakasugi H; Ibayashi H
    Thromb Haemost; 1984 Jul; 51(3):313-6. PubMed ID: 6495252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Platelet aggregation and von Willebrand's factor in 32 insulin-dependent diabetics. Value of the measurement of filtration pressure in the presence of ADP].
    Prost-Dvojakovic RJ; Lecrubier C; Lanoe R; Batchvarova V; Samama M
    Journ Annu Diabetol Hotel Dieu; 1976 May; ():239-47. PubMed ID: 1087675
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of labile aggregation-stimulating substance (LASS) and platelet aggregation in diabetes mellitus.
    Colwell JA; Chambers A; Laimins M
    Diabetes; 1975 Jul; 24(7):684-7. PubMed ID: 1158034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.